Document is current
Any future updates will be listed below
-
Authors
Hashimoto, Daisuke
Satoi, Sohei
Yamaki, So
Nakayama, Shinji
Shibata, Nobuhiro
Matsumura, Kazuki
Miyazaki, Hidetaka
Matsui, Yuki
Tsybulskyi, Denys
Sang, Nguyen Thanh
Ikeura, Tsukasa
Kanai, Masashi
Sekimoto, Mitsugu
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 28 September 2024
First Online: 21 October 2024
Disclosures
: S.S. declared research fundings from Nihon Servier, Amino-up Co. and Boston Scientific. M.S. declared research fundings from Eisai co. N.S. declares Consulting or advisory roles for Kyowa Kirin Co., Ltd., and Daiichi Sankyo Co., Ltd.; Speaker’s bureau from Kyowa Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Pfzer Japan Inc., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Yakult Honsha Co., Ltd., Taiho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., MSD K.K., Merck Biopharma Co., Ltd., Bayer Yakuhin, Ltd., Eli Lilly Japan K.K., and Becton, Dickinson and Company. Research funding from Daiichi Sankyo Co., Ltd., and MSD K.K. The remaining authors report no conflict of interest.
: The study was reviewed and approved (No. 2020131) by the Institutional Review Board of Kansai Medical University, Japan.
: The records of patients who refused access to their data were excluded from the analysis.
: N/A
